170 related articles for article (PubMed ID: 27406386)
1. Expression of metalloproteinases (MMP-2 and MMP-9) in basal-cell carcinoma.
Goździalska A; Wojas-Pelc A; Drąg J; Brzewski P; Jaśkiewicz J; Pastuszczak M
Mol Biol Rep; 2016 Oct; 43(10):1027-33. PubMed ID: 27406386
[TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
[TBL] [Abstract][Full Text] [Related]
4. [Expression of MMP-2, MMP-9 and collagen type IV and their relationship in colorectal carcinomas].
Wu W; He JT; Ruan JD; Wang RB; Zhang YD
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):908-9. PubMed ID: 18782525
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of alpha1 (IV) and alpha5 (IV) collagen chains in basal-cell carcinoma.
Quatresooz P; Martalo O; Piérard GE
J Cutan Pathol; 2003 Oct; 30(9):548-52. PubMed ID: 14507402
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of basal lamina type IV collagen α chains, matrix metalloproteinases-2 and -9 expressions in oral dysplasia and invasive carcinoma.
Tamamura R; Nagatsuka H; Siar CH; Katase N; Naito I; Sado Y; Nagai N
Acta Histochem; 2013 Mar; 115(2):113-9. PubMed ID: 22694915
[TBL] [Abstract][Full Text] [Related]
7. Peritumoral Clefting and Expression of MMP-2 and MMP-9 in Basal Cell Carcinoma of the Skin.
Manola I; Mataic A; Drvar DL; Pezelj I; Dzombeta TR; Kruslin B
In Vivo; 2020; 34(3):1271-1275. PubMed ID: 32354918
[TBL] [Abstract][Full Text] [Related]
8. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
[TBL] [Abstract][Full Text] [Related]
9. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
10. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
11. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.
Bartoš V; Kullová M
Cesk Patol; 2016; 52(4):222-226. PubMed ID: 27869450
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.
Bartoš V; Kullová M
Acta Dermatovenerol Croat; 2015; 23(4):254-9. PubMed ID: 26724876
[TBL] [Abstract][Full Text] [Related]
13. Artesunate modulates expression of matrix metalloproteinases and their inhibitors as well as collagen-IV to attenuate pulmonary fibrosis in rats.
Wang Y; Huang G; Mo B; Wang C
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323108
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
[TBL] [Abstract][Full Text] [Related]
15. High numbers of human skin cancers express MMP2 and several integrin genes.
Orimoto AM; Neto CF; Pimentel ER; Sanches JA; Sotto MN; Akaishi E; Ruiz IR
J Cutan Pathol; 2008 Mar; 35(3):285-91. PubMed ID: 18251742
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas.
Boaventura P; Pereira D; Mendes A; Batista R; da Silva AF; Guimarães I; Honavar M; Teixeira-Gomes J; Lopes JM; Máximo V; Soares P
J Dermatol Sci; 2014 Jan; 73(1):31-9. PubMed ID: 24091058
[TBL] [Abstract][Full Text] [Related]
17. Selectively enhanced procollagen gene expression in sclerosing (morphea-like) basal cell carcinoma as reflected by elevated pro alpha 1(I) and pro alpha 1(III) procollagen messenger RNA steady-state levels.
Moy RL; Moy LS; Matsuoka LY; Bennett RG; Uitto J
J Invest Dermatol; 1988 May; 90(5):634-8. PubMed ID: 3361139
[TBL] [Abstract][Full Text] [Related]
18. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
19. Invasiveness and MMP expression in pancreatic carcinoma.
Yang X; Staren ED; Howard JM; Iwamura T; Bartsch JE; Appert HE
J Surg Res; 2001 Jun; 98(1):33-9. PubMed ID: 11368535
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical study of the specific features of expression of matrix metalloproteinases 1, 9 in the photoaged skin, the foci of actinic keratosis and basal cell carcinoma].
Kuznetsova EV; Snarskaya ES; Zavalishina LE; Tkachenko SB
Arkh Patol; 2016; 78(6):17-22. PubMed ID: 28139598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
